Try it
Pharmacology · Haematology: hydroxyurea in sickle cell disease
Sample itemA child with sickle cell anaemia has frequent painful crises. Which drug reduces crises by raising fetal haemoglobin?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Hydroxyurea
Hydroxyurea inhibits ribonucleotide reductase and increases HbF production, which interferes with sickling and lowers crisis frequency and acute chest syndrome. Myelosuppression is its main toxicity.
Option by option
A. Deferasirox
Deferasirox is a chelator.
B. Hydroxyurea (correct)
Correct. Hydroxyurea raises HbF.
C. Folic acid alone
Folic acid supports erythropoiesis but does not alter sickling.
D. Aspirin
Aspirin is not a disease-modifying agent.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?